Fennec Pharmaceuticals (FENC)

• Market cap: $276M
• 1 day: 5.48%
• 5 days: 6.87%
• 1 month: 2.53%
• 3 months: -10.51%
• 6 months: -2.29%
• Year to date: 28.62%
• 1 year: 27%
• 5 years: 9.62%
• 10 years: -32.58%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32